PB2333: CAR-T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B-NHL

Podobne zapisy

• CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier
  od: Danyang Li, i wsp.
  Wydane: (2026-01-01)
• Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications
  od: Epameinondas Koumpis, i wsp.
  Wydane: (2024-07-01)
• CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases
  od: Jovana Vukovic, i wsp.
  Wydane: (2024-10-01)
• Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment
  od: Brandon Park, i wsp.
  Wydane: (2025-06-01)
• Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
  od: Abigail Cheever, i wsp.
  Wydane: (2022-11-01)